GLP-1/GIP RAs clinical guidance updated
Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have been updated.
Representatives from ANZCA, the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed the revised recommendations, which now include a decision-aid flowchart linked to explanatory statements.
They now also include a clear statement regarding the recommendation not to withhold these drugs prior to a procedure.
The revised document is available here. Please send any feedback or queries to [email protected]
You might also be interested in...
The following candidates have been successful in the 2025.1 primary examination.
A report recognising a shortfall of anaesthetists in NSW has been welcomed by the Australian and New Zealand College of Anaesthetists (ANZCA).
New this month: ACHS QI Awards; ACSQHC NSQHS 3rd ed.; TGA advisory committee vacancies; webAIRS ANZCA ASM media release.